Among patients with Hb ≤ 11.9 g/dL, those with a maximum tumor diameter of ≤49 mm had an OS rate of 90.5%, while patients with a tumor diameter >49 mm had a lower OS rate of 62.1%. This evidence concerns the gene GSTM1 and neoplasm.